Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Gestational Trophoblastic Neoplasms
and you are
under 60
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This clinical trial is designed to study the effect and safety of paclitaxel plus cisplatin as the first-line regimen in the treatment of high risk gestational trophoblastic tumor.

Provided treatments

  • Drug: Etoposide
  • Drug: actinomycin D
  • Drug: methotrexate
  • Drug: vincristine
  • Drug: cyclophosphamide
  • Drug: Paclitaxel
  • Drug: Cisplatin
  • Drug: Carboplatin
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02639650. The sponsor of the trial is Weiguo Lv and it is looking for 214 volunteers for the current phase.
Official trial title:
A Prospective Randomized Multicenter Clinical Control Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor